HK1071301A1 - Ophthalmic composition comprising ascomycin - Google Patents

Ophthalmic composition comprising ascomycin

Info

Publication number
HK1071301A1
HK1071301A1 HK05104167A HK05104167A HK1071301A1 HK 1071301 A1 HK1071301 A1 HK 1071301A1 HK 05104167 A HK05104167 A HK 05104167A HK 05104167 A HK05104167 A HK 05104167A HK 1071301 A1 HK1071301 A1 HK 1071301A1
Authority
HK
Hong Kong
Prior art keywords
ascomycin
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
HK05104167A
Other languages
English (en)
Inventor
Maggy Babiole Saunier
Jean-Claude Bizec
Pik-Han Wong Michelle
Shau-Fong Yen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1071301(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1071301A1 publication Critical patent/HK1071301A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK05104167A 2002-03-04 2005-05-18 Ophthalmic composition comprising ascomycin HK1071301A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en) 2002-03-04 2003-03-03 Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number Publication Date
HK1071301A1 true HK1071301A1 (en) 2005-07-15

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104167A HK1071301A1 (en) 2002-03-04 2005-05-18 Ophthalmic composition comprising ascomycin

Country Status (28)

Country Link
US (4) US20050220823A1 (xx)
EP (1) EP1482936B1 (xx)
JP (1) JP4740542B2 (xx)
KR (1) KR100992948B1 (xx)
CN (1) CN1297270C (xx)
AR (1) AR038628A1 (xx)
AT (1) ATE341326T1 (xx)
AU (1) AU2003218679B2 (xx)
BR (1) BR0308184A (xx)
CA (1) CA2477769C (xx)
CO (1) CO5611133A2 (xx)
DE (1) DE60308836T2 (xx)
DK (1) DK1482936T3 (xx)
EC (1) ECSP045277A (xx)
EG (1) EG24403A (xx)
ES (1) ES2274214T3 (xx)
HK (1) HK1071301A1 (xx)
IL (2) IL163657A0 (xx)
MX (1) MXPA04008571A (xx)
MY (1) MY137563A (xx)
NO (1) NO20044092L (xx)
NZ (1) NZ534690A (xx)
PE (1) PE20030828A1 (xx)
PL (1) PL210870B1 (xx)
PT (1) PT1482936E (xx)
RU (1) RU2322982C2 (xx)
TW (1) TW200305437A (xx)
WO (1) WO2003074054A1 (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100355455C (zh) 2002-07-15 2007-12-19 爱尔康公司 用于眼内使用的非聚合亲脂性药物植入组合物
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en) 2009-04-09 2010-10-13 Nestec S.A. Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
SI2429510T1 (sl) 2009-05-12 2015-10-30 Galenica Ab Emulzija olja v vodi mometazona in propilen glikola
SG10201500152UA (en) * 2009-12-22 2015-03-30 Abbvie Inc Abt-263 capsule
US20110251285A1 (en) * 2010-04-07 2011-10-13 Allergan, Inc. Combinations of preservatives for ophthalmic compositions
RU2531937C2 (ru) * 2012-05-14 2014-10-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
US20160074321A1 (en) * 2013-03-27 2016-03-17 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
US11103464B2 (en) * 2013-11-29 2021-08-31 Rohto Pharmaceutical Co., Ltd. Aqueous composition for ophthalmological use or otolaryngological use
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA905202B (en) * 1989-07-05 1991-04-24 Fujisawa Pharmaceutical Co Aqueous liquid composition for external use
ATE150304T1 (de) * 1990-09-04 1997-04-15 Fujisawa Pharmaceutical Co Tricyclische verbindungen enthaltende salben
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
DE69328368T2 (de) * 1992-08-28 2000-08-10 Pharmos Corp Emulsionen im submikron-bereich als vehikel zur arzneistoffverabreichung am auge
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
ATE196734T1 (de) * 1993-08-18 2000-10-15 Alcon Lab Inc Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
CN1089233C (zh) * 1994-10-26 2002-08-21 诺瓦蒂斯有限公司 药物组合物
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
IL139210A (en) * 1998-04-27 2005-11-20 Fujisawa Pharmaceutical Co Pharmaceutical composition containing a macrolide compound
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
ES2232439T3 (es) * 1999-04-30 2005-06-01 Sucampo Ag Uso de compuestos macrolidos para el tratamiento de los ojos secos.

Also Published As

Publication number Publication date
EP1482936A1 (en) 2004-12-08
US20100113501A1 (en) 2010-05-06
CN1638769A (zh) 2005-07-13
ES2274214T3 (es) 2007-05-16
ECSP045277A (es) 2004-10-26
ATE341326T1 (de) 2006-10-15
CA2477769A1 (en) 2003-09-12
AU2003218679A1 (en) 2003-09-16
US20120015971A1 (en) 2012-01-19
DE60308836D1 (de) 2006-11-16
CN1297270C (zh) 2007-01-31
PL370917A1 (en) 2005-06-13
CA2477769C (en) 2011-01-18
WO2003074054A1 (en) 2003-09-12
EG24403A (en) 2009-04-29
PL210870B1 (pl) 2012-03-30
RU2004129593A (ru) 2005-09-10
EP1482936B1 (en) 2006-10-04
PE20030828A1 (es) 2003-11-04
KR20040094718A (ko) 2004-11-10
JP4740542B2 (ja) 2011-08-03
NZ534690A (en) 2007-06-29
PT1482936E (pt) 2007-01-31
MXPA04008571A (es) 2004-12-06
BR0308184A (pt) 2005-01-11
IL163657A0 (en) 2005-12-18
CO5611133A2 (es) 2006-02-28
AR038628A1 (es) 2005-01-19
DK1482936T3 (da) 2007-01-08
MY137563A (en) 2009-02-27
RU2322982C2 (ru) 2008-04-27
US20110152307A1 (en) 2011-06-23
DE60308836T2 (de) 2007-04-26
KR100992948B1 (ko) 2010-11-08
TW200305437A (en) 2003-11-01
US20050220823A1 (en) 2005-10-06
AU2003218679B2 (en) 2007-04-05
NO20044092L (no) 2004-09-27
IL163657A (en) 2009-11-18
JP2005529851A (ja) 2005-10-06

Similar Documents

Publication Publication Date Title
HK1071301A1 (en) Ophthalmic composition comprising ascomycin
AU150854S (en) Glasses
GB0220467D0 (en) Composition
GB0213638D0 (en) Composition
IL160374A0 (en) Ophthalmic composition comprising an ascomycin
GB0318894D0 (en) Composition
GB0203421D0 (en) Composition
GB0227244D0 (en) Composition
GB0208608D0 (en) Composition
GB0203280D0 (en) Anti-glycolytic composition
EP1661573A4 (en) OPHTHALMIC COMPOSITION
GB0211924D0 (en) Composition
EP1647273A4 (en) OPHTHALMIC COMPOSITION
GB0318152D0 (en) Composition
GB0218241D0 (en) Composition
HK1082517A1 (en) Oil-barrier composition
EP1495751A4 (en) hair dye
SI1482936T1 (sl) Oftalmicni sestavek, ki vkljucuje askomicin
GB0229286D0 (en) Composition
GB0213767D0 (en) Composition
EP1586324A4 (en) COMPOSITION FOR EYE TREATMENT
GB0203616D0 (en) Composition
GB0205702D0 (en) Hydrogel compositions
AU151750S (en) Glasses
EP1533355A4 (en) ULTRAVIOLETTABSORBIEREN COMPOSITION

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110303